In ovarian cancer, P53 is a useful marker to distinguish between HGSOC, mutated in 96% of the cases [35], and low-grade serous ovarian carcinoma (LGSOC), were mutations are very rare [1, 36]. This evidence concerns the gene TP53 and ovarian cancer.